The Discounted Cash Flow (DCF) valuation of Cannabics Pharmaceuticals Inc (CNBX) is (7.99) USD. With the latest stock price at 0.00 USD, the upside of Cannabics Pharmaceuticals Inc based on DCF is -887555.1%.
Based on the latest price of 0.00 USD and our DCF valuation, Cannabics Pharmaceuticals Inc (CNBX) is a sell. selling CNBX stocks now will result in a potential gain of 887555.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.2% - 5.3% | 5.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (38.55) - (4.71) | (7.99) |
| Upside | -4282997.0% - -523575.1% | -887555.1% |